FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2000968555> ?p ?o ?g. }

• W2000968555 endingPage "745" @default.
• W2000968555 startingPage "739" @default.
• W2000968555 abstract "IL-4 and IL-13 play a putative role in mucus hypersecretion in asthma. Suplatast tosilate prevents the synthesis of T(H2) cytokines.Because suplatast tosilate inhibits T(H2) cytokines but does not inhibits IFN-gamma production, we examined the effect of suplatast on IL-4- or IL-13- and ovalbumin (OVA)-induced mucin synthesis in NCI-H292 cells in vitro and in bronchi of pathogen-free BALB/c mice in vivo.In vitro, NCI-H292 cells were preincubated with suplatast tosilate (0.1-100 microgram/mL) 1 hour before adding human recombinant IL-4 (10 ng/mL). In vivo, mouse recombinant IL-4 or IL-13 (250 ng per/mouse) was instilled intranasally in mice pretreated with suplatast tosilate (50 mg.kg(-1).d(-1)). Mucous glycoconjugates were stained with Alcian blue (AB)/periodic acid-Schiff (PAS) stain. To evaluate effects of suplatast tosilate on goblet-cell metaplasia in OVA-sensitized mice, animals were pretreated with suplatast tosilate (1-50 mg.kg(-1).d(-1)) intragastrically. IL-4 and IL-13 were measured, and allergic inflammatory cells were analyzed in bronchoalveolar lavage fluid of OVA-sensitized mice.Pretreatment with suplastast did not prevent IL-4- or IL-13-induced increase in mucous glycoconjugate production in NCI-H292 cells or in mice. OVA sensitization increased AB/PAS-stained area of the epithelium (48.1% +/- 2.4%, P <.01 compared with control mice). Suplatast tosilate inhibited OVA-induced goblet-cell metaplasia in airway epithelium in a dose-dependent fashion; 50 mg.kg(-1).d(-1) decreased the AB/PAS area to 22.7% +/- 2.7% (P <.05 compared with OVA sensitization alone). Pretreatment with suplatast tosilate also prevented OVA-induced increase in IL-4 and IL-13 levels and decreased the number of lymphocytes and eosinophils in bronchoalveolar lavage fluid (P <.05 compared with values of mice given OVA alone).These results indicate that suplatast tosilate prevents allergen-induced goblet-cell metaplasia and the recruitment of eosinophils and lymphocytes into the airways. These results suggest that this effect is due to the prevention of the production of T(H2) cytokines in airways." @default.
• W2000968555 created "2016-06-24" @default.
• W2000968555 creator A5010127199 @default.
• W2000968555 creator A5024323899 @default.
• W2000968555 creator A5038028170 @default.
• W2000968555 creator A5054997551 @default.
• W2000968555 creator A5071921056 @default.
• W2000968555 creator A5087522944 @default.
• W2000968555 creator A5087545549 @default.
• W2000968555 date "2000-04-01" @default.
• W2000968555 modified "2023-10-17" @default.
• W2000968555 title "Suplatast tosilate inhibits goblet-cell metaplasia of airway epithelium in sensitized mice" @default.
• W2000968555 cites W1531889930 @default.
• W2000968555 cites W1964022595 @default.
• W2000968555 cites W1983910410 @default.
• W2000968555 cites W2043764313 @default.
• W2000968555 cites W2051429239 @default.
• W2000968555 cites W2071265116 @default.
• W2000968555 cites W2072815966 @default.
• W2000968555 cites W2082860580 @default.
• W2000968555 cites W2108786544 @default.
• W2000968555 cites W2110817651 @default.
• W2000968555 cites W2111699101 @default.
• W2000968555 cites W2120184224 @default.
• W2000968555 cites W2124566107 @default.
• W2000968555 cites W2125805192 @default.
• W2000968555 cites W2166881631 @default.
• W2000968555 cites W4313376897 @default.
• W2000968555 doi "https://doi.org/10.1067/mai.2000.105221" @default.
• W2000968555 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/10756224" @default.
• W2000968555 hasPublicationYear "2000" @default.
• W2000968555 type Work @default.
• W2000968555 sameAs 2000968555 @default.
• W2000968555 citedByCount "38" @default.
• W2000968555 countsByYear W20009685552012 @default.
• W2000968555 countsByYear W20009685552013 @default.
• W2000968555 countsByYear W20009685552014 @default.
• W2000968555 countsByYear W20009685552015 @default.
• W2000968555 countsByYear W20009685552019 @default.
• W2000968555 countsByYear W20009685552020 @default.
• W2000968555 countsByYear W20009685552023 @default.
• W2000968555 crossrefType "journal-article" @default.
• W2000968555 hasAuthorship W2000968555A5010127199 @default.
• W2000968555 hasAuthorship W2000968555A5024323899 @default.
• W2000968555 hasAuthorship W2000968555A5038028170 @default.
• W2000968555 hasAuthorship W2000968555A5054997551 @default.
• W2000968555 hasAuthorship W2000968555A5071921056 @default.
• W2000968555 hasAuthorship W2000968555A5087522944 @default.
• W2000968555 hasAuthorship W2000968555A5087545549 @default.
• W2000968555 hasBestOaLocation W20009685551 @default.
• W2000968555 hasConcept C142724271 @default.
• W2000968555 hasConcept C150903083 @default.
• W2000968555 hasConcept C153911025 @default.
• W2000968555 hasConcept C179264091 @default.
• W2000968555 hasConcept C185592680 @default.
• W2000968555 hasConcept C18903297 @default.
• W2000968555 hasConcept C202751555 @default.
• W2000968555 hasConcept C203014093 @default.
• W2000968555 hasConcept C207001950 @default.
• W2000968555 hasConcept C2775941134 @default.
• W2000968555 hasConcept C2776042228 @default.
• W2000968555 hasConcept C2776217527 @default.
• W2000968555 hasConcept C2776946954 @default.
• W2000968555 hasConcept C2777037409 @default.
• W2000968555 hasConcept C2777312293 @default.
• W2000968555 hasConcept C529295009 @default.
• W2000968555 hasConcept C55493867 @default.
• W2000968555 hasConcept C71924100 @default.
• W2000968555 hasConcept C86803240 @default.
• W2000968555 hasConcept C87568996 @default.
• W2000968555 hasConcept C8891405 @default.
• W2000968555 hasConceptScore W2000968555C142724271 @default.
• W2000968555 hasConceptScore W2000968555C150903083 @default.
• W2000968555 hasConceptScore W2000968555C153911025 @default.
• W2000968555 hasConceptScore W2000968555C179264091 @default.
• W2000968555 hasConceptScore W2000968555C185592680 @default.
• W2000968555 hasConceptScore W2000968555C18903297 @default.
• W2000968555 hasConceptScore W2000968555C202751555 @default.
• W2000968555 hasConceptScore W2000968555C203014093 @default.
• W2000968555 hasConceptScore W2000968555C207001950 @default.
• W2000968555 hasConceptScore W2000968555C2775941134 @default.
• W2000968555 hasConceptScore W2000968555C2776042228 @default.
• W2000968555 hasConceptScore W2000968555C2776217527 @default.
• W2000968555 hasConceptScore W2000968555C2776946954 @default.
• W2000968555 hasConceptScore W2000968555C2777037409 @default.
• W2000968555 hasConceptScore W2000968555C2777312293 @default.
• W2000968555 hasConceptScore W2000968555C529295009 @default.
• W2000968555 hasConceptScore W2000968555C55493867 @default.
• W2000968555 hasConceptScore W2000968555C71924100 @default.
• W2000968555 hasConceptScore W2000968555C86803240 @default.
• W2000968555 hasConceptScore W2000968555C87568996 @default.
• W2000968555 hasConceptScore W2000968555C8891405 @default.
• W2000968555 hasIssue "4" @default.
• W2000968555 hasLocation W20009685551 @default.
• W2000968555 hasLocation W20009685552 @default.
• W2000968555 hasOpenAccess W2000968555 @default.
• W2000968555 hasPrimaryLocation W20009685551 @default.
• W2000968555 hasRelatedWork W1981720530 @default.

• next